Diphenyl diselenide supplementation reduces biochemical alterations associated with oxidative stress in rats fed with fructose and hydrochlorothiazide

Chemico-Biological Interactions

Volumn 204, Issue 3, 2013, Pages 191-199

  Ribeiro, Marinei Cristina Pereira ^a   Ávila, Daiana Silva ^b   Schiar, Viviane Patrícia Pires ^a   Dos Santos, Danúbia Bonfanti ^a   Meinerz, Daiane F ^a   Duarte, Marta Medeiros Frescura ^a   Monteiro, Roger ^a   Puntel, Robson ^b   De Bem, Andreza Fabro ^c   Hassan, Waseem ^a,d   De Vargas Barbosa, Nilda Berenice ^a   Rocha, João Batista Teixeira ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d UNIVERSITY OF PESHAWAR   (Pakistan)

Author keywords

Diphenyl diselenide; High fructose diet; Hydrochlorothiazide; Oxidative stress

Indexed keywords

ASCORBIC ACID; CATALASE; CHOLESTEROL; CREATININE; DIPHENYL DISELENIDE; FRUCTOSAMINE; FRUCTOSE; GLUCOSE; HYDROCHLOROTHIAZIDE; MAGNESIUM; POTASSIUM; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UREA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FLUID INTAKE; FOOD INTAKE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; ORGAN WEIGHT; PROTEIN CARBONYLATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; RATTUS;

EID: 84984582347     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.05.008     Document Type: Article

References (64)

1. D. Leroith, Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes, Am. J. Med. Sci. 343 (2012) 6-13.
2. M. Soleimani, Dietary fructose, salt absorption and hypertension in metabolic syndrome: towards a new paradigm, Acta Physiol. (Oxford) 201 (2011) 55-62.
3. B. Cannizzo, A. Luján, N. Estrella, C. Lembo, M. Cruzado, C. Castro, Insulin resistance promotes early atherosclerosis via increased proinflammatory proteins and oxidative stress in fructose fed ApoE-KO mice, Exp. Diabetes Res. (2012), http://dx.doi.org/10.1155/2012/941304.
4. V.B. Brito, V. Folmer, J.C.M. Soares, I.D. Silveira, J.B.T. Rocha, Long-term sucrose and glucose consumption decreases the aminolevulinate dehydratase activity in mice, Nutrition 23 (2007) 818-826.
5. J.R. Sowers, P.K. Mohanty, Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients, Circulation 75 (1987) 170-173.
6. F.H. Messerli, S. Bangalore, Half a century of hydrochlorothiazide: facts, fads, fiction, and follies, Am. J. Med. 124 (2011) 896-899.
7. D.S. Siscovick, T.E. Raghunathan, B.M. Psaty, et al., Diuretic therapy for hypertension and the risk of primary cardiac arrest, N. Engl. J. Med. 330 (1994) 1852-1857.
8. Medical Research Council trial of treatment of hypertension in older adults: principal results, MRC working party, BMJ 304 (1992) 405-412.
9. MRC trial of treatment of mild hypertension: principal results, Medical research council working party, Br. Med. J. (Clin. Res. Ed.) 291 (1985) 97-104.
10. J.J. Dinicolantonio, Hydrochlorothiazide: is it a wise choice?, Expert Opin Pharmacother (2012) 283; J.J. Dinicolantonio, Hydrochlorothiazide: is it a wise choice?, Expert Opin Pharmacother 13 (2012) 807-814.
11. F.H. Messerli, S. Bangalore, Half a century of hydrochlorothiazide: facts, fads, fiction and 281 follies, Am. J. Med. 124 (2011) 896-899 (282 11).
12. H.V. Desai, K. Gandh, M. Sharma, M. Jennine, P. Singh, M. Brogan, Thiazideinduced severe hypercalcemia: a case report and review of literature, Am. J .Ther. 17 (2010) 234-236.
13. D.A. Sica, B. Carter, W. Cushman, L. Hamm, Thiazide and loop diuretics, J. Clin. Hypertens. (Greenwich) 13 (2011) 639-643.
14. P. Verdecchia, G. Reboldi, F. Angeli, C. Borgioni, R. Gattobigio, L. Filippucci, S. Norgiolini, C. Bracco, C. Porcellati, Adverse prognostic significance of new diabetes in treated hypertensive subjects, Hypertension 43 (2004) 963-969.
15. S. Reungjui, C.A. Roncal, W. Mu, T.R. Srinivas, D. Sirivongs, R.J. Johnson, T. Nakagawa, Thiazide Diuretics Exacerbate Fructose-Induced Metabolic Syndrome, J. Am. Soc. Nephrol. 18 (2007) 2724-2731.
16. M.P. Rayman, The importance of selenium to human health, Lancet 356 (2000) 233-241.
17. M.P. Rayman, Selenium and human health, Lancet 379 (9822) (2012 Mar 31) 1256-1268.
18. C.W. Nogueira, J.B.T. Rocha, Diphenyl diselenide a janus-faced molecule, J. Braz. Chem. Soc. 21 (2010) 2055-2071.
19. G.F. Combs, P.G. Gray, Chemopreventive agents: selenium, Pharmacol. Ther. 79 (1998) 179-192.
20. O. Ezaki, The insulin-like effects of selenate in rat adipocytes, J. Biol. Chem. 265 (1990) 1124-1130.
21. D. Bonnefont-Rousselot, The role of antioxidant micronutrients in the prevention of diabetic complications, Treat. Endocrinol. 3 (2004) 41-52.
22. C.W. Nogueira, J.B.T. Rocha, Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds, Arch. Toxicol. 85 (11) (2011) 1313-1359.
23. N.B.V. Barbosa, J.B.T. Rocha, J.C.M. Soares, D.C. Wondracek, J.F. Goncalves, M.R.C. Schetinger, C.W. Nogueira, Dietary diphenyl diselenide reduces the STZinduced toxicity, Food Chem. Toxicol. 46 (2008) 186-194.
24. C. Paulmier, Selenium Reagents and Intermediates in Organic Synthesis, Pergamon Books, Oxford, UK, 1986.
25. P. Faure, D. Barclay, M. Joyeux-Faure, S. Halimi, Comparison of the effects of zinc alone and zinc associated with selenium and vitamin E on insulin sensitivity and oxidative stress in high fructose-fed rats, J. Trace Elem. Med Biol. 21 (2007) 113-119.
26. H.U. Bergmeyer, Methods of Enzimatic Analisys, third ed., Deerfield Beach, Veriag Chemie, 1984. 6 (pp. 163-172).
27. J.R. Baker, P.A. Metcalf, R.N. Johnson, D. Newman, P. Rietz, Use of protein-based standards in automated colorimetric determinations of fructosamine in serum, Clin. Chem. 31 (1985) 1550-1554.
28. C.C. Allain, L.S. Poon, C.S.G. Chan, W. Richmond, P.C. Fu, Enzymatic determination of total serum-cholesterol, Clin. Chem. 20 (1974) 470-475.
29. G. Bucolo, H. David, Quantitative-determination of serum triglycerides by use of enzymes, Clin. Chem. 19 (1973) 476-482.
30. C. Bohuon, Microdetermination of magnesium in biological fluids, Clin. Chim. Acta 7 (1962) 811-817.
31. K. Kavanagh, J.N. Mills, Measuring electrolytes: an evaluation of the IDEXX Vetlyte ion selective electrode method, Aust. Vet. Pract. 27 (1997) 97-102.
32. H.U. Bergmeyer, Methods of Enzymatic Analisys, thidr ed., Deerfield Beach, 8 (1985) 444-449.
33. H. Yatzidis, New method for direct determination of true creatinine, Clin. Chem. 20 (1974) 1131-1134.
34. R.L. Puntel, D.H. Roos, D. Grotto, S.C. Garcia, C.W. Nogueira, J.B. Rocha, Antioxidant properties of Krebs cycle intermediates against malonate prooxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates, Life Sci. 81 (1) (2007 Jun 13) 51-62.
35. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A. Lenz, B. Ahn, S. Shaltiel, E.R. Stadtman, Determination of carbonyl content in oxidatively modified proteins, Methods Enzymol. 186 (1989) 464-478.
36. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
37. M.C. Jacques-Silva, C.W. Nogueira, L.C. Broch, E.M. Flores, J.B.T. Rocha, Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice, Pharmacol. Toxicol. 88 (2001) 119-125.
38. H. Aebi, Catalase ''in vitro'', Methods Enzymol. 105 (1984) 121-127.
39. H.P. Misra, I. Fridovich, A peroxide-dependent reduction of cytochrome-C by NADH, Biochim. Biophys. Acta 3 (1972) 815-824.
40. A.M. Zee, S.T. Turner, G.L. Schwartz, A.B. Chapman, O.H. Klungel, E. Boerwinkle, Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects, Am. J. Hypertens. 18 (2005) 1077-1083.
41. S.S. Reddy, P. Ramatholisamma, R. Karuna, D. Saralakumari, Preventive effect of Tinospora cordifolia against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats, Food Chem. Toxicol. 47 (2009) 2224- 2229.
42. E. Ho, N. Quan, Y.H. Tsai, W. Lai, T.M. Bray, Dietary zinc supplementation inhibits NF-kappa B activation protects against chemically induced diabetes, Exp. Biol. Med. 226 (2001) 103-111.
43. P.N. Chander, O. Gealekman, S.V. Brodsky, S. Elitok, A. Tojo, M. Crabtree, S.S. Gross, S. Goligorsky, Nephropathy in zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen, J. Am. Soc. Nephrol. 15 (2004) 2391-2403.
44. M. Miranda, M. Muriach, J. Roma, F. Bosh-Morell, J.M. Genoves, J. Barcia, J. Araiz, M. Diaz Llospis, F.J. Romero, Oxidative stress in a model for experimental diabetic retinopathy: the utility of peroxinitrite scavengers, Arch. Soc. Esp. Oftalm. 81 (2006) 27-32.
45. M. Naziroglu, M. Cay, Protective role of intraperitoneally administered vitamin E and selenium on the antioxidative defense mechanisms in rats with diabetes induced by streptozotocin, Biol. Trace Elem. Res. 79 (2001) 149-159.
46. P. Faure, Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus, Clin. Chem. Lab. Med. 41 (2003) 995-998.
47. P. Faure, O. Ramon, A. Favier, S. Halimi, Selenium supplementation decreases nuclear factor kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients, Eur. J. Clin. Invest. 34 (2004) 475-481.
48. Patricia A. McAdam, A. Levander Orville, Chronic toxicity retention of dietary selenium fed to rats as D- or L-selenomethionine selenite or selenate, Nutr. Res. 7 (1987) 601-610.
49. A.S. de Freitas, A.S. Prestes, C. Wagner, J.H. Sudati, D. Alves, L.O. Porciúncula, I.J. Kade, J.B.T. Rocha, Reduction of diphenyl diselenide analogs by mammalian thioredoxin reductase is independent of their gluthathione peroxidase-like activity: a possible novel pathway for their antioxidant activity, Molecules 15 (2010) 7414-7699.
50. Maiese, S.D. Morhan, Z.Z. Chong, Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus, Curr. Neurovasc. Res. 4 (2007) 63-71.
51. C.J. Mullarkey, D. Edelstein, M. Brownlee, Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes, Biochem. Biophys. Res. Commun. 173 (1990) 932-939.
52. J.P. Lopes, S.M. Oliveira, J.S. Fortunato, Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications, Acta Med. Port. 213 (2008) 293-302.
53. G. Bonner, Hyperinsulinemia, insulin resistance, and hypertension, J. Cardiovasc. Pharmacol. 24 (1994) 39-49.
54. T. Dyckner, P.O. Wester, The relation between extraand intracellular electrolytes in patients with hypokalemia and/or diuretic treatment, Acta Med. Scand. 204 (1978) 269-282.
55. T. Dyckner, P.O. Wester, Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment, Am. Heart 97 (1979) 12-18.
56. J.W. Hollifield, Thiazide treatment of hypertension: effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy, Am. J. Med. 80 (1986) 8-12.
57. R. Solomon, The relationship between disorders of K and Mg homeostasis, Semin. Nephrol. 7 (1987) 253-262.
58. R. Whang, J.K. Aikawa, Magnesium deficiency and refractoriness to potassium repletion, J. Chronic Dis. 30 (1977) 65-68.
59. I.D. Weiner, C.S. Wingo, Hypokalemia: consequences, causes, and correction, J. Am. Soc. Nephrol. 8 (1997) 1179-1188.
60. R. Whang, L.A. Welt, Observations in experimental magnesium depletion, J. Clin. Invest. 42 (1963) 305-313.
61. N.L.M. Wong, R.A. Sutton, V. Navichak, G.A. Quame, J.H. Dirks, Enhanced distal absorption of potassium by magnesium-deficient rats, Clin. Sci. 69 (1985) 626- 639.
62. C.L. Huang, E. KuoJ, Mechanism of hypokalemia in magnesium deficiency, Am. Soc. Nephrol. 18 (2007) 2649-2652.
63. P. Weidmann, M. Courten, P. Ferrari, Effects of diuretics on the plasma lipid profile, Eur. Heart J. 13 (1992) 61-67.
64. M. Barbagallo, L.J. Dominguez, A. Galioto, A. Ferlisi, C. Cani, L. Malfa, A. Pineo, A. Busardo, G. Paolisso, Role of magnesium in insulin action, diabetes and cardiometabolic syndrome X, Mol. Aspects Med. 24 (2003) 39-52.